@article{f23085e7952b447ea59173be6e0ac2b8,
title = "Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases",
keywords = "COVID-19, autoimmune diseases, epidemiology, vaccination",
author = "Connolly, {Caoilfhionn M.} and Ruddy, {Jake A.} and Boyarsky, {Brian J.} and Avery, {Robin K.} and Werbel, {William A.} and Segev, {Dorry L.} and Jacqueline Garonzik-Wang and Paik, {Julie J.}",
note = "Funding Information: Funding This research was made possible with generous support of the Ben-Dov family. This work was supported by grant number F32DK124941 (Boyarsky) and K23DK115908 (Garonzik-Wang) from the National Institute of Diabetes and Digestive and Kidney Diseases, K24AI144954 (Segev) from National Institute of Allergy and Infectious Diseases, K23AR073927 (Paik) from National Institute of Arthritis and Musculoskeletal and Skin Diseases and by a grant from the Transplantation and Immunology Research Network of the American Society of Transplantation (Werbel). The analyses described here are the responsibility of the authors alone and do not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organisations imply endorsement by the US Government.",
year = "2021",
month = aug,
day = "1",
doi = "10.1136/annrheumdis-2021-220231",
language = "English (US)",
volume = "80",
pages = "1100--1101",
journal = "Annals of the rheumatic diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "8",
}